Completed NA INTERVENTIONAL 2-arm NCT03907423

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

Effects of Rosuvastatin on Markers of Atherosclerosis in Diabetic Patients Treated With Glimepiride/Metformin Combination

Sponsor: Rehab Werida

Conditions Diabetes Mellitus, Type 2

Interventions Placebo Oral Tablet Rosuvastatin10 mg tablet

Updated 8 times since 2019 Last updated: Apr 12, 2023 Started: Apr 1, 2019 Primary completion: Jan 19, 2021 Completion: Jan 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetes Mellitus, Type 2, this trial is completed. The trial is conducted by Rehab Werida and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA
Apr 2023 — May 2023 [monthly]

Completed NA
Mar 2021 — Apr 2023 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Mar 2021 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
May 2019 — Sep 2020 [monthly]

Recruiting NA

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rehab Werida

Data source: Damanhour University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Damanhūr, Egypt